The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Viral Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
The global Viral Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Viral Vaccines in various end use industries. The expanding demands from the Hospital, Pharmaceutical Factory, Research Institute and Others, are propelling Viral Vaccines market. Attenuated Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inactivated Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Vaccines covered in this report include GSK, Merck, Novartis, Pfizer, Sanofi, Bayer, Zoetis, AstraZeneca and Johnson, etc.
The global Viral Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL
Global Viral Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Vaccines market, Segment by Type:
Attenuated Vaccine
Inactivated Vaccine
Global Viral Vaccines market, by Application
Hospital
Pharmaceutical Factory
Research Institute
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Viral Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Viral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Viral Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Viral Vaccines in various end use industries. The expanding demands from the Hospital, Pharmaceutical Factory, Research Institute and Others, are propelling Viral Vaccines market. Attenuated Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inactivated Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Vaccines covered in this report include GSK, Merck, Novartis, Pfizer, Sanofi, Bayer, Zoetis, AstraZeneca and Johnson, etc.
The global Viral Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL
Global Viral Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Vaccines market, Segment by Type:
Attenuated Vaccine
Inactivated Vaccine
Global Viral Vaccines market, by Application
Hospital
Pharmaceutical Factory
Research Institute
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Viral Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Viral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Viral Vaccines Market Overview
1.1 Viral Vaccines Product Overview
1.2 Viral Vaccines Market Segment by Type
1.2.1 Attenuated Vaccine
1.2.2 Inactivated Vaccine
1.3 Global Viral Vaccines Market Size by Type
1.3.1 Global Viral Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Viral Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Viral Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Viral Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Viral Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Viral Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Viral Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Viral Vaccines Sales Breakdown by Type (2018-2023)
2 Global Viral Vaccines Market Competition by Company
2.1 Global Top Players by Viral Vaccines Sales (2018-2023)
2.2 Global Top Players by Viral Vaccines Revenue (2018-2023)
2.3 Global Top Players by Viral Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Viral Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Viral Vaccines Market Competitive Situation and Trends
2.5.1 Viral Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Viral Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Viral Vaccines Market
2.8 Key Manufacturers Viral Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Viral Vaccines Status and Outlook by Region
3.1 Global Viral Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Viral Vaccines Historic Market Size by Region
3.2.1 Global Viral Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Viral Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Viral Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Viral Vaccines Forecasted Market Size by Region
3.3.1 Global Viral Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Viral Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Viral Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Viral Vaccines by Application
4.1 Viral Vaccines Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmaceutical Factory
4.1.3 Research Institute
4.1.4 Others
4.2 Global Viral Vaccines Market Size by Application
4.2.1 Global Viral Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Viral Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Viral Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Viral Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Viral Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Viral Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Viral Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Viral Vaccines Sales Breakdown by Application (2018-2023)
5 North America Viral Vaccines by Country
5.1 North America Viral Vaccines Historic Market Size by Country
5.1.1 North America Viral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Viral Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Viral Vaccines Sales in Value by Country (2018-2023)
5.2 North America Viral Vaccines Forecasted Market Size by Country
5.2.1 North America Viral Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Viral Vaccines Sales in Value by Country (2024-2029)
6 Europe Viral Vaccines by Country
6.1 Europe Viral Vaccines Historic Market Size by Country
6.1.1 Europe Viral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Viral Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Viral Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Viral Vaccines Forecasted Market Size by Country
6.2.1 Europe Viral Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Viral Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Viral Vaccines by Region
7.1 Asia-Pacific Viral Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Viral Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Viral Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Viral Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Viral Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Viral Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Viral Vaccines Sales in Value by Region (2024-2029)
8 Latin America Viral Vaccines by Country
8.1 Latin America Viral Vaccines Historic Market Size by Country
8.1.1 Latin America Viral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Viral Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Viral Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Viral Vaccines Forecasted Market Size by Country
8.2.1 Latin America Viral Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Viral Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Viral Vaccines by Country
9.1 Middle East and Africa Viral Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Viral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Viral Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Viral Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Viral Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Viral Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Viral Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Viral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Viral Vaccines Products Offered
10.1.5 GSK Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Viral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Viral Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Viral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Viral Vaccines Products Offered
10.3.5 Novartis Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Viral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Viral Vaccines Products Offered
10.4.5 Pfizer Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Viral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sanofi Viral Vaccines Products Offered
10.5.5 Sanofi Recent Development
10.6 Bayer
10.6.1 Bayer Company Information
10.6.2 Bayer Introduction and Business Overview
10.6.3 Bayer Viral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bayer Viral Vaccines Products Offered
10.6.5 Bayer Recent Development
10.7 Zoetis
10.7.1 Zoetis Company Information
10.7.2 Zoetis Introduction and Business Overview
10.7.3 Zoetis Viral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Zoetis Viral Vaccines Products Offered
10.7.5 Zoetis Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Viral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 AstraZeneca Viral Vaccines Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Johnson
10.9.1 Johnson Company Information
10.9.2 Johnson Introduction and Business Overview
10.9.3 Johnson Viral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Johnson Viral Vaccines Products Offered
10.9.5 Johnson Recent Development
10.10 CSL
10.10.1 CSL Company Information
10.10.2 CSL Introduction and Business Overview
10.10.3 CSL Viral Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CSL Viral Vaccines Products Offered
10.10.5 CSL Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Viral Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Viral Vaccines Industrial Chain Analysis
11.4 Viral Vaccines Market Dynamics
11.4.1 Viral Vaccines Industry Trends
11.4.2 Viral Vaccines Market Drivers
11.4.3 Viral Vaccines Market Challenges
11.4.4 Viral Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Viral Vaccines Distributors
12.3 Viral Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
